Sequential Immunization of Melanoma Patients With GD3 Ganglioside Vaccine and Anti-Idiotypic Monoclonal Antibody That Mimics GD3 Ganglioside
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-0345
Full Text
Open PDFAbstract
Available in full text
Date
July 15, 2004
Authors
Publisher
American Association for Cancer Research (AACR)